Cargando…
[Retracted] Isoquercitrin inhibits the progression of pancreatic cancer in vivo and in vitro by regulating opioid receptors and the mitogen‑activated protein kinase signalling pathway
Autores principales: | Chen, Quan, Li, Ping, Xu, Yong, Li, Yang, Tang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996682/ https://www.ncbi.nlm.nih.gov/pubmed/36825589 http://dx.doi.org/10.3892/or.2023.8505 |
Ejemplares similares
-
[Retracted] Isoquercitrin inhibits the progression of liver cancer in vivo and in vitro via the MAPK signalling pathway
por: Huang, Guihong, et al.
Publicado: (2023) -
Upregulation of the δ opioid receptor in liver cancer promotes liver cancer progression both in vitro and in vivo
por: Tang, Bo, et al.
Publicado: (2023) -
[Retracted] MicroRNA‑136 inhibits prostate cancer cell proliferation and invasion by directly targeting mitogen‑activated protein kinase kinase 4
por: Zhu, Yudi, et al.
Publicado: (2023) -
Retracted: Improvement of Gut Microbiota by Inhibition of P38 Mitogen-Activated Protein Kinase (MAPK) Signaling Pathway in Rats with Severe Acute Pancreatitis
por: Wan, You-Dong, et al.
Publicado: (2022) -
Retraction: Targeted Knockdown of IQGAP1 Inhibits the Progression of Esophageal Squamous Cell Carcinoma In Vitro and In Vivo
Publicado: (2022)